Request Demo
Last update 25 Aug 2025
HSK-39004
Last update 25 Aug 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HSK39004 |
Target |
Action inhibitors |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors), PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with HSK-39004NCT07108699
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK39004 Dry Powder Inhaler in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
NCT07140328
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
CTR20251411
一项评价HSK39004吸入混悬液和HSK39004吸入粉雾剂治疗慢性阻塞性肺疾病（COPD）的药代动力学、有效性和安全性的多中心、随机、双盲、安慰剂对照、平行设计的II期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled, parallel-design Phase II clinical study to evaluate the pharmacokinetics, efficacy and safety of HSK39004 inhalation suspension and HSK39004 inhalation powder in the treatment of chronic obstructive pulmonary disease (COPD)
100 Clinical Results associated with HSK-39004
Login to view more data
100 Translational Medicine associated with HSK-39004
Login to view more data
100 Patents (Medical) associated with HSK-39004
Login to view more data
100 Deals associated with HSK-39004
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 2 | China | 24 Apr 2025 | |
| Bronchitis, Chronic | IND Approval | China | 08 Feb 2025 | |
| Bronchitis, Chronic | IND Approval | China | 08 Feb 2025 | |
| Pulmonary Emphysema | IND Approval | China | 08 Feb 2025 | |
| Pulmonary Emphysema | IND Approval | China | 08 Feb 2025 | |
| Asthma | IND Application | China | 11 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free